©2024 Stanford Medicine
A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis
Not Recruiting
Trial ID: NCT00185562
Purpose
A 12 week trial of Adalimumab in subjects with active erosive inflammatory OA who have ahd an
inadequate response to NSAID therapy
Official Title
A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis
Stanford Investigator(s)
Mark Genovese
James W. Raitt M.D. Professor, Emeritus
Eligibility
Inclusion Criteria:
- Age 45 or older, >/=2 tender and 2 swollen joints, inadequate response to NSAID
therapy, hand radiographs with evidence of erosive changes, acceptable form of birth
control
Exclusion Criteria:
- Autoimmune arthropathy, History of psoriasis, Previous TNF therapy, current use of any
DMARD, evidence of TB, history of Hep C, B, or HIV
Intervention(s):
drug: Adalimumab
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305